Cargando…
Concanamycin A counteracts HIV-1 Nef to enhance immune clearance of infected primary cells by cytotoxic T lymphocytes
Nef is an HIV-encoded accessory protein that enhances pathogenicity by down-regulating major histocompatibility class I (MHC-I) expression to evade killing by cytotoxic T lymphocytes (CTLs). A potent Nef inhibitor that restores MHC-I is needed to promote immune-mediated clearance of HIV-infected cel...
Autores principales: | Painter, Mark M., Zimmerman, Gretchen E., Merlino, Madeline S., Robertson, Andrew W., Terry, Valeri H., Ren, Xuefeng, McLeod, Megan R., Gomez-Rodriguez, Lyanne, Garcia, Kirsten A., Leonard, Jolie A., Leopold, Kay E., Neevel, Andrew J., Lubow, Jay, Olson, Eli, Piechocka-Trocha, Alicja, Collins, David R., Tripathi, Ashootosh, Raghavan, Malini, Walker, Bruce D., Hurley, James H., Sherman, David H., Collins, Kathleen L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519347/ https://www.ncbi.nlm.nih.gov/pubmed/32900948 http://dx.doi.org/10.1073/pnas.2008615117 |
Ejemplares similares
-
Mannose receptor is an HIV restriction factor counteracted by Vpr in macrophages
por: Lubow, Jay, et al.
Publicado: (2020) -
SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef
por: Usami, Yoshiko, et al.
Publicado: (2015) -
HIV-1 Nef Targets MHC-I and CD4 for Degradation Via a Final Common
β-COP–Dependent Pathway in T Cells
por: Schaefer, Malinda R., et al.
Publicado: (2008) -
Chemoresistance to Concanamycin A1 in Human Oral Squamous Cell Carcinoma Is Attenuated by an HDAC Inhibitor Partly via Suppression of Bcl-2 Expression
por: Kiyoshima, Tamotsu, et al.
Publicado: (2013) -
Impaired ability of Nef to counteract SERINC5 is associated with reduced plasma viremia in HIV-infected individuals
por: Toyoda, Mako, et al.
Publicado: (2020)